title: Assessment of potential digoxin-rabeprazole interaction after formulary conversion of proton-pump inhibitors.
authors.affiliation: Veterans Affairs San Diego Healthcare System (VASDHS), 3350 La Jolla Village Drive, San Diego, CA 92161, USA.
authors.forename: Grace H
authors.initials: GH
authors.lastname: Le
authors.forename: Monica G
authors.initials: MG
authors.lastname: Schaefer
authors.forename: Brian K
authors.initials: BK
authors.lastname: Plowman
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Morreale
authors.forename: Melissa
authors.initials: M
authors.lastname: Delattre
authors.forename: Lisa
authors.initials: L
authors.lastname: Okino
authors.forename: Leda
authors.initials: L
authors.lastname: Felicio
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000368:Aged; D001562:Benzimidazoles / Q000494:pharmacology* / Q000627:therapeutic use; D004077:Digoxin / Q000097:blood* / Q000627:therapeutic use; D004347:Drug Interactions; D005572:Formularies, Hospital as Topic; D006801:Humans; D064747:Lansoprazole; D008297:Male; D009853:Omeprazole / Q000031:analogs & derivatives / Q000627:therapeutic use; D011446:Prospective Studies; D054328:Proton Pump Inhibitors; D064750:Rabeprazole
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D004077:Digoxin; D009853:Omeprazole